HIP1
Huntingtin-interacting protein 1
Also known as: HIP1_HUMAN, ILWEQ
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00291
- Gene
- HIP1
- Ensembl
- ENSG00000127946
- Chromosome
- 7
- Canonical length
- 1037 aa
- Protein class
- Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Vesicles,Acrosome,Mid piece,Principal piece
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The product of this gene is a membrane-associated protein that functions in clathrin-mediated endocytosis and protein trafficking within the cell. The encoded protein binds to the huntingtin protein in the brain; this interaction is lost in Huntington's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
1037 residues, UniProt reviewed canonical sequence.
>O00291|HIP1
1 MDRMASSMKQ VPNPLPKVLS RRGVGAGLEA AERESFERTQ TVSINKAINT QEVAVKEKHA
61 RTCILGTHHE KGAQTFWSVV NRLPLSSNAV LCWKFCHVFH KLLRDGHPNV LKDSLRYRNE
121 LSDMSRMWGH LSEGYGQLCS IYLKLLRTKM EYHTKNPRFP GNLQMSDRQL DEAGESDVNN
181 FFQLTVEMFD YLECELNLFQ TVFNSLDMSR SVSVTAAGQC RLAPLIQVIL DCSHLYDYTV
241 KLLFKLHSCL PADTLQGHRD RFMEQFTKLK DLFYRSSNLQ YFKRLIQIPQ LPENPPNFLR
301 ASALSEHISP VVVIPAEASS PDSEPVLEKD DLMDMDASQQ NLFDNKFDDI FGSSFSSDPF
361 NFNSQNGVNK DEKDHLIERL YREISGLKAQ LENMKTESQR VVLQLKGHVS ELEADLAEQQ
421 HLRQQAADDC EFLRAELDEL RRQREDTEKA QRSLSEIERK AQANEQRYSK LKEKYSELVQ
481 NHADLLRKNA EVTKQVSMAR QAQVDLEREK KELEDSLERI SDQGQRKTQE QLEVLESLKQ
541 ELATSQRELQ VLQGSLETSA QSEANWAAEF AELEKERDSL VSGAAHREEE LSALRKELQD
601 TQLKLASTEE SMCQLAKDQR KMLLVGSRKA AEQVIQDALN QLEEPPLISC AGSADHLLST
661 VTSISSCIEQ LEKSWSQYLA CPEDISGLLH SITLLAHLTS DAIAHGATTC LRAPPEPADS
721 LTEACKQYGR ETLAYLASLE EEGSLENADS TAMRNCLSKI KAIGEELLPR GLDIKQEELG
781 DLVDKEMAAT SAAIETATAR IEEMLSKSRA GDTGVKLEVN ERILGCCTSL MQAIQVLIVA
841 SKDLQREIVE SGRGTASPKE FYAKNSRWTE GLISASKAVG WGATVMVDAA DLVVQGRGKF
901 EELMVCSHEI AASTAQLVAA SKVKADKDSP NLAQLQQASR GVNQATAGVV ASTISGKSQI
961 EETDNMDFSS MTLTQIKRQE MDSQVRVLEL ENELQKERQK LGELRKKHYE LAGVAEGWEE
1021 GTEASPPTLQ EVVTEKELocalizationUniProt · AlphaFold · HPA
Whether an antibody against HIP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- testis: 29 nTPM
- blood vessel: 26 nTPM
- spinal cord: 24 nTPM
- placenta: 19 nTPM
- lung: 18 nTPM
- cerebral cortex: 17 nTPM
Single-cell type
- late spermatids: 2,446 nCPM
- loop of henle epithelial cells: 870 nCPM
- oligodendrocyte progenitor cells: 546 nCPM
- renal collecting duct principal cells: 537 nCPM
- distal convoluted tubule cells: 532 nCPM
- oligodendrocytes: 516 nCPM
Immune cell
- basophil: 9.6 nTPM
- eosinophil: 6.9 nTPM
- neutrophil: 6.8 nTPM
- plasmacytoid DC: 3.3 nTPM
- NK-cell: 3 nTPM
- T-reg: 1.4 nTPM
Brain region
- white matter: 99 nTPM
- basal ganglia: 76 nTPM
- midbrain: 70 nTPM
- medulla oblongata: 69 nTPM
- thalamus: 69 nTPM
- cerebral cortex: 65 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.76
- gnomAD missense Z
- 2.27
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- apoptotic process
- apoptotic signaling pathway
- cell differentiation
- clathrin coat assembly
- endocytosis
- positive regulation of epidermal growth factor receptor signaling pathway
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of platelet-derived growth factor receptor-beta signaling pathway
- positive regulation of receptor-mediated endocytosis
- presynaptic modulation of chemical synaptic transmission
- protein stabilization
- regulation of apoptotic process
- regulation of endocytosis
- regulation of postsynaptic neurotransmitter receptor internalization
- neurotransmitter receptor transport
Molecular functions
- actin filament binding
- AP-2 adaptor complex binding
- clathrin adaptor activity
- clathrin binding
- clathrin light chain binding
- epidermal growth factor receptor binding
- glutamate receptor binding
- phosphatidylinositol binding
- phosphatidylinositol-3,4-bisphosphate binding
- phosphatidylinositol-3,5-bisphosphate binding
- phosphatidylinositol-3-phosphate binding
- protein heterodimerization activity
- protein homodimerization activity
- structural constituent of cytoskeleton
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HIP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HIP1 as an antibody target. Whether an autoantibody or antibody against HIP1 could matter depends on whether native HIP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HIP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HIP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...